Clofabosin: Difference between revisions
| Line 362: | Line 362: | ||
Yes-no questions are formed by adding the question particle ''pegol'' to the subjunctive: ''Zenazumab pegol?'' (Did he go?). However, colloquial speech often shortens this to ''-ma'gol'' or even ''-ma'l''. "What" questions do ''not'' use this ending: ''cesin gliserotin(avir)?'' = what language is this? | Yes-no questions are formed by adding the question particle ''pegol'' to the subjunctive: ''Zenazumab pegol?'' (Did he go?). However, colloquial speech often shortens this to ''-ma'gol'' or even ''-ma'l''. "What" questions do ''not'' use this ending: ''cesin gliserotin(avir)?'' = what language is this? | ||
The negative uses the ''-flo-'' marker after the verb stem: ''sabaflovir'' 'he does not write' (usually pronounced [sabafloiɾ] or [sabafloːr]). For subjunctive forms, the negative marker is ''-tu(m)-'': ''Sabatumab!'' or ''Sabatumomab!'' means 'Don't write!' | The negative uses the ''-flo-'' marker after the verb stem: ''sabaflovir'' 'he does not write' (usually pronounced [sabafloiɾ] or [sabafloːr]). For subjunctive forms, the negative marker is ''-tu(m)-'': ''Sabatumab!'', ''Sabatumumab!'' or ''Sabatumomab!'' means 'Don't write!' | ||
*'can' (ability) uses ''-tecan'' (inflected as if it were ''-tecavir''; the attributive is ''-taxel'') | *'can' (ability) uses ''-tecan'' (inflected as if it were ''-tecavir''; the attributive is ''-taxel'') | ||